Skip to content
Catalyst

metforminPapers

Papers about metformin

papers
3,984
41 years, by papers

Newest first

3,501 to 3,550 of 3,984

Every paper here, unless its row says otherwiseIndexed under metformin in PubMed's chemical list; returned by a PubMed search for metformin

  • An open-label pilot study of the combination therapy of metformin and fluoxetine for weight reduction.

    International journal of obesity (2005)2007PMID 16969361Indexed under metformin in PubMed's chemical list

  • Effects of metformin and rosiglitazone in HIV-infected patients with hyperinsulinemia and elevated waist/hip ratio.

    AIDS (London, England)2007PMID 17148967

  • A comparison of twice-daily exenatide and biphasic insulin aspart in patients with type 2 diabetes who were suboptimally controlled with sulfonylurea and metformin: a non-inferiority study.

    Diabetologia2007PMID 17160407

  • Oral antidiabetic drugs: bioavailability assessment of fixed-dose combination tablets of pioglitazone and metformin. Effect of body weight, gender, and race on systemic exposures of each drug.

    Journal of clinical pharmacology2007PMID 17192500

  • Oral antidiabetic drugs: effect of food on absorption of pioglitazone and metformin from a fixed-dose combination tablet.

    Journal of clinical pharmacology2007PMID 17192501

  • Effects of rosiglitazone and metformin on inflammatory markers and adipokines: decrease in interleukin-18 is an independent factor for the improvement of homeostasis model assessment-beta in type 2 diabetes mellitus.

    Clinical endocrinology2007PMID 17224000

  • Metabolic effects of pioglitazone and rosiglitazone in patients with diabetes and metabolic syndrome treated with metformin.

    Internal medicine journal2007PMID 17229249

  • Metformin versus oral contraceptive pill in polycystic ovary syndrome: a Cochrane review.

    Human reproduction (Oxford, England)2007PMID 17261574

  • Metformin improves skin capillary reactivity in normoglycaemic subjects with the metabolic syndrome.

    Diabetic medicine2007PMID 17263761

  • Are the beneficial cardiovascular effects of simvastatin and metformin also associated with a hormone-dependent mechanism improving insulin sensitivity?

    Brazilian journal of medical and biological research2007PMID 17273659Indexed under metformin in PubMed's chemical list

  • Effects of vildagliptin on glucose control over 24 weeks in patients with type 2 diabetes inadequately controlled with metformin.

    Diabetes care2007PMID 17277036

  • Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome.

    The New England journal of medicine2007PMID 17287476

  • Insulin counter-regulatory factors, fibrinogen and C-reactive protein during olanzapine administration: effects of the antidiabetic metformin.

    International clinical psychopharmacology2007PMID 17293706

  • Combined low-dose pioglitazone, flutamide, and metformin for women with androgen excess.

    The Journal of clinical endocrinology and metabolism2007PMID 17299064

  • Effect of adding sitagliptin, a dipeptidyl peptidase-4 inhibitor, to metformin on 24-h glycaemic control and beta-cell function in patients with type 2 diabetes.

    Diabetes, obesity & metabolism2007PMID 17300594

  • Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, compared with the sulfonylurea, glipizide, in patients with type 2 diabetes inadequately controlled on metformin alone: a randomized, double-blind, non-inferiority trial.

    Diabetes, obesity & metabolism2007PMID 17300595

  • A randomized trial of the effects of rosiglitazone and metformin on inflammation and subclinical atherosclerosis in patients with type 2 diabetes.

    American heart journal2007PMID 17307426

  • The mushroom Agaricus Blazei Murill in combination with metformin and gliclazide improves insulin resistance in type 2 diabetes: a randomized, double-blinded, and placebo-controlled clinical trial.

    Journal of alternative and complementary medicine (New York, N.Y.)2007PMID 17309383

  • Metformin treatment in pregnant women with polycystic ovary syndrome--is reduced complication rate mediated by changes in the uteroplacental circulation?

    Ultrasound in obstetrics & gynecology2007PMID 17330831

  • Effects of metformin or rosiglitazone on serum concentrations of homocysteine, folate, and vitamin B12 in patients with type 2 diabetes mellitus.

    Journal of diabetes and its complications2007PMID 17331860

  • Prospective, randomized trial of metformin and vitamins for the reduction of plasma homocysteine in insulin-resistant polycystic ovary syndrome.

    Fertility and sterility2007PMID 17336970

  • Homocysteine levels are unaffected by metformin treatment in both nonpregnant and pregnant women with polycystic ovary syndrome.

    Acta obstetricia et gynecologica Scandinavica2007PMID 17364275

  • Short-term effects of metformin in type 2 diabetes.

    Diabetes, obesity & metabolism2007PMID 17391159

  • Targeting hyperglycaemia with either metformin or repaglinide in non-obese patients with type 2 diabetes: results from a randomized crossover trial.

    Diabetes, obesity & metabolism2007PMID 17391168

  • Glimepiride versus metformin as monotherapy in pediatric patients with type 2 diabetes: a randomized, single-blind comparative study.

    Diabetes care2007PMID 17392540

  • Factors associated with diabetes onset during metformin versus placebo therapy in the diabetes prevention program.

    Diabetes2007PMID 17395752

  • A double-blind randomized study comparing the effects of continuing or not continuing rosiglitazone + metformin therapy when starting insulin therapy in people with Type 2 diabetes.

    Diabetic medicine2007PMID 17403121

  • A randomized controlled trial examining combinations of repaglinide, metformin and NPH insulin.

    Diabetic medicine2007PMID 17403126

  • The effects of metformin and rosiglitazone, alone and in combination, on the ovary and endometrium in polycystic ovary syndrome.

    American journal of obstetrics and gynecology2007PMID 17403436

  • Metformin plus low-dose glimeperide significantly improves Homeostasis Model Assessment for insulin resistance (HOMA(IR)) and beta-cell function (HOMA(beta-cell)) without hyperinsulinemia in patients with type 2 diabetes mellitus.

    American journal of therapeutics2007PMID 17414590

  • Comparison of ethinyl-estradiol plus cyproterone acetate versus metformin effects on classic metabolic cardiovascular risk factors in women with the polycystic ovary syndrome.

    The Journal of clinical endocrinology and metabolism2007PMID 17426085

  • Comparison of two doses of metformin (2.5 and 1.5 g/day) for the treatment of polycystic ovary syndrome and their effect on body mass index and waist circumference.

    Fertility and sterility2007PMID 17433315

  • A comparison of mealtime insulin aspart and human insulin in combination with metformin in type 2 diabetes patients.

    Diabetes research and clinical practice2007PMID 17445933

  • Treatment options for type 2 diabetes in adolescents and youth: a study of the comparative efficacy of metformin alone or in combination with rosiglitazone or lifestyle intervention in adolescents with type 2 diabetes.

    Pediatric diabetes2007PMID 17448130

  • Comparison of the effects of pioglitazone and metformin on insulin resistance and hormonal markers in patients with impaired glucose tolerance and early diabetes.

    Hypertension research2007PMID 17460368

  • Effect of initial combination therapy with sitagliptin, a dipeptidyl peptidase-4 inhibitor, and metformin on glycemic control in patients with type 2 diabetes.

    Diabetes care2007PMID 17485570

  • Metformin as an adjunctive treatment to control body weight and metabolic dysfunction during olanzapine administration: a multicentric, double-blind, placebo-controlled trial.

    Schizophrenia research2007PMID 17490862

  • Simultaneous assay of metformin and glibenclamide in human plasma based on extraction-less sample preparation procedure and LC/(APCI)MS.

    Journal of chromatography2007PMID 17500048

  • Comparison between vildagliptin and metformin to sustain reductions in HbA(1c) over 1 year in drug-naïve patients with Type 2 diabetes.

    Diabetic medicine2007PMID 17509069

  • Bioequivalence study of two metformin formulations.

    Arzneimittel-Forschung2007PMID 17515289

  • Insulin sensitivity after metformin suspension in normal-weight women with polycystic ovary syndrome.

    The Journal of clinical endocrinology and metabolism2007PMID 17519312

  • Increased body iron stores of obese women with polycystic ovary syndrome are a consequence of insulin resistance and hyperinsulinism and are not a result of reduced menstrual losses.

    Diabetes care2007PMID 17536071Indexed under metformin in PubMed's chemical list

  • Short-term effects of metformin in type 2 diabetes.

    Diabetes, obesity & metabolism2007PMID 17587390

  • Nateglinide or gliclazide in combination with metformin for treatment of patients with type 2 diabetes mellitus inadequately controlled on maximum doses of metformin alone: 1-year trial results.

    Diabetes, obesity & metabolism2007PMID 17587393

  • Blood pressure control and inflammatory markers in type 2 diabetic patients treated with pioglitazone or rosiglitazone and metformin.

    Hypertension research2007PMID 17587750

  • Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, in patients with type 2 diabetes mellitus inadequately controlled on glimepiride alone or on glimepiride and metformin.

    Diabetes, obesity & metabolism2007PMID 17593236

  • Effects of simvastatin and metformin on inflammation and insulin resistance in individuals with mild metabolic syndrome.

    American journal of cardiovascular drugs2007PMID 17610348Indexed under metformin in PubMed's chemical list

  • Both slow-release and regular-form metformin improve glycemic control without altering plasma visfatin level in patients with type 2 diabetes mellitus.

    Metabolism: clinical and experimental2007PMID 17618954

  • Comparison of extended-release metformin in combination with a sulfonylurea (glyburide) to sulfonylurea monotherapy in adult patients with type 2 diabetes: a multicenter, double-blind, randomized, controlled, phase III study.

    Clinical therapeutics2007PMID 17697903

  • Effects of pioglitazone in combination with metformin or a sulfonylurea compared to a fixed-dose combination of metformin and glibenclamide in patients with type 2 diabetes.

    Diabetes technology & therapeutics2007PMID 17705695

The next 50 papers

← Previous 50